Literature DB >> 14927797

The use of adjuvants in studies on influenza immunization. I. Measurements in monkeys of the dimensions of antigenicity of virus-mineral oil emulsions.

J E SALK, A M LAURENT.   

Abstract

Untoward reactions at the site of inoculation were not observed in monkeys vaccinated with influenza virus incorporated in a water-in-oil emulsion without acid-fast bacilli. Studies were then made to measure some of the dimensions of antigenicity of these emulsions to evaluate the extent of the immunologic adjuvant effect. This included measurements of height and persistence of the antibody response to inoculation and measurements of the extent to which the vaccine could be diluted and still induce antibody formation; i.e., antigenic extinction. In addition, comparisons were made of the rates of development of hemagglutination-inhibiting, virus-neutralizing, and complement-fixing antibody activities to determine the relationship among these three properties of the serum of immunized animals. It was found that levels of antibody many fold higher were induced by the virus-adjuvant mixtures as compared with virus in an aqueous menstruum, and that the level of antibody induced was related to the quantity of antigen incorporated in the emulsion. The stock vaccine when emulsified could be diluted 100,000-fold and was still active in antibody formation whereas a 100-fold dilution of the antigen without emulsification was essentially ineffective. Equivalent quantities of virus in 0.1 ml. or 1.0 ml. of emulsion induced antibody responses that were indistinguishable with respect to level or persistence. In comparing the course of antibody development it was found that hemagglutination-inhibiting, virus-neutralizing, and complement-fixing antibodies develop at different rates; careful analysis of the data derived from the present study together with other observations warrant the conclusion that these antibody activities are not present in constant proportion and are independent of one another. The implications of this observation and of the others mentioned above are discussed.

Entities:  

Keywords:  INFLUENZA VIRUS

Mesh:

Substances:

Year:  1952        PMID: 14927797      PMCID: PMC2212081          DOI: 10.1084/jem.95.5.429

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  9 in total

1.  Formation of neutralizing antibody in monkeys injected with poliomyelitis virus and adjuvants.

Authors:  R WARD; D RADER; M M LIPTON; J FREUND
Journal:  Proc Soc Exp Biol Med       Date:  1950-07

2.  The use of adjuvants to facilitate studies on the immunologic classification of poliomyelitis viruses.

Authors:  J E SALK; L J LEWIS; J S YOUNGNER; B L BENNETT
Journal:  Am J Hyg       Date:  1951-09

3.  A Plastic Plate for Use in Tests Involving Virus Hemagglutination and Other Similar Reactions.

Authors:  J E Salk
Journal:  Science       Date:  1948-12-31       Impact factor: 47.728

4.  THE IMMUNIZING EFFECT OF CALCIUM PHOSPHATE ADSORBED INFLUENZA VIRUS.

Authors:  J E Salk
Journal:  Science       Date:  1945-02-02       Impact factor: 47.728

5.  Direction of research on vaccination against influenza; new studies with immunologic adjuvants.

Authors:  J E SALK; A M LAURENT; M L BAILEY
Journal:  Am J Public Health Nations Health       Date:  1951-06

6.  The formation of complement fixing and neutralizing antibodies after the injection of inactivated rabies virus with adjuvants.

Authors:  M M LIPTON; J FREUND
Journal:  J Immunol       Date:  1950-04       Impact factor: 5.422

7.  ANTIBODY RESPONSE OF HUMAN BEINGS FOLLOWING VACCINATION WITH INFLUENZA VIRUSES.

Authors:  G K Hirst; E R Rickard; L Whitman; F L Horsfall
Journal:  J Exp Med       Date:  1942-05-01       Impact factor: 14.307

8.  QUANTITATIVE ASPECTS OF THE RED BLOOD CELL AGGLUTINATION TEST FOR INFLUENZA VIRUS.

Authors:  G L Miller; W M Stanley
Journal:  J Exp Med       Date:  1944-02-01       Impact factor: 14.307

9.  ADJUVANTS IN IMMUNIZATION WITH INFLUENZA VIRUS VACCINES.

Authors:  W F Friedewald
Journal:  J Exp Med       Date:  1944-12-01       Impact factor: 14.307

  9 in total
  28 in total

1.  SEROLOGICAL STUDIES ON ADULT VOLUNTEERS INOCULATED WITH OIL-ADJUVANT ASIAN INFLUENZA VACCINE. REPORT TO THE M.R.C. COMMITTEE ON INFLUENZA AND OTHER RESPIRATORY VIRUS VACCINES.

Authors:  D HOBSON; C A LANE; A S BEARE; C P CHIVERS
Journal:  Br Med J       Date:  1964-08-01

2.  Antigenic structures of Haemophilus aegyptius and Haemophilus influenzae demonstrated by the gel precipitation technique.

Authors:  A L OLITZKI; A SULITZEANU
Journal:  J Bacteriol       Date:  1959-03       Impact factor: 3.490

3.  Studies on the chemical basis of the antigenicity of proteins. 5. Synthesis, characterization and immunogenicity of some multichain and linear polypeptides containing tyrosine.

Authors:  M SELA; S FUCHS; R ARNON
Journal:  Biochem J       Date:  1962-10       Impact factor: 3.857

4.  Hemagglutinin inhibition with ether-treated antigen as a more sensitive method to measure the immunological response to an Asian influenza virus vaccine.

Authors:  G H WERNER; R SHARMA; L GOGOLSKI
Journal:  Arch Gesamte Virusforsch       Date:  1960

5.  Relative merits of aqueous and adjuvant influenza vaccines when used in a two-dose schedule.

Authors:  A V HENNESSY; F M DAVENPORT
Journal:  Public Health Rep       Date:  1961-05       Impact factor: 2.792

6.  Action of phospholipids on the cytotoxic effect of rabbit antibodies against Ehrilich ascites tumour cells.

Authors:  I GINSBURG
Journal:  Br J Exp Pathol       Date:  1960-12

7.  Purification of staphylococcal coagulase.

Authors:  H BLOBEL; D T BERMAN; J SIMON
Journal:  J Bacteriol       Date:  1960-06       Impact factor: 3.490

8.  Studies on the chemical basis of the antigenicity of proteins. 1. Antigenicity of polypeptidyl gelatins.

Authors:  M SELA; R ARNON
Journal:  Biochem J       Date:  1960-04       Impact factor: 3.857

9.  Studies on the antigenic structure of Brucella suis with the aid of the agar gel precipitation technique. I. The resistance of antigens to physical, chemical and enzymatic treatments.

Authors:  A L OLITZKI; D SULITZEANU
Journal:  Br J Exp Pathol       Date:  1958-06

10.  Complement-fixing antibodies in guinea pigs immunized with type 3 adenopharyngoconjunctival virus.

Authors:  G H WERNER
Journal:  J Bacteriol       Date:  1956-10       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.